Altrazeal Life Sciences Inc.
DelistedCIK 1168220fmd_0A50FBQMF7GAXBVSWBZ2M55DEBManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2018, 34 periods
| Line item | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | 2 | 0 | 0 | 0 | 1 | 1 | 0 | 1 |
| Cost of revenue | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Gross profit | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Research and development | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Selling, general and administrative | 3 | 2 | 2 | 1 | 2 | 2 | 1 | 1 |
| Operating income | (4) | (4) | (3) | (3) | (3) | (2) | (4) | (2) |
| Interest expense | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Income before taxes | (5) | (4) | (4) | (3) | (2) | (3) | (4) | (2) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (5) | (4) | (4) | (3) | (2) | (3) | (4) | (2) |
| Net income | (5) | (4) | (4) | (3) | (2) | (3) | (4) | (2) |
| Net income to common shareholders | (5) | (4) | (4) | (3) | (2) | – | – | – |